Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk
other	Depression or Irritability	Psychiatric disorders	Peptide T	7	106
other	Depression or Irritability	Psychiatric disorders	Placebo	1	109
other	Rash	Skin and subcutaneous tissue disorders	Peptide T	34	106
other	Rash	Skin and subcutaneous tissue disorders	Placebo	42	109
other	Nasal Congestion	Respiratory, thoracic and mediastinal disorders	Peptide T	12	106
other	Nasal Congestion	Respiratory, thoracic and mediastinal disorders	Placebo	5	109
other	Proteinuria	Renal and urinary disorders	Peptide T	18	106
other	Proteinuria	Renal and urinary disorders	Placebo	9	109
other	Eosinophilia	Blood and lymphatic system disorders	Peptide T	4	106
other	Eosinophilia	Blood and lymphatic system disorders	Placebo	0	109
serious	Death	Immune system disorders	Peptide T	8	106
serious	Death	Immune system disorders	Placebo	3	109

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00000392/events